Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio

[PR Newswire] – THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., May 27, 2014 /PRNewswire/ — Amgen (AMGN) and its subsidiary Onyx Pharmaceuticals, Inc., today announced data from several studies of both pipeline . . . → Read More: Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio Similar Articles: Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen’s First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Webcast of 2014 First Quarter Financial Results Amgen Inc (NASDAQ:AMGN) – Amgen To Webcast Investor Meeting At Upcoming American College of Cardiology’s 63rd Annual Scientific Session
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.